TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/16/2026
Back to search
Official data from USPTO
JOURNAL OF HEMATOLOGY ONCOLOGY PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
JOURNAL OF HEMATOLOGY ONCOLOGY PHARMACY
ST13
US500000090705904Class
16
Filing
90705904
Registration
6674310
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
03/18/2026
Trademark type
Word
Nice classes
16
Filing date
05/12/2021
Registration date
03/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/15/2022
Last transaction
03/18/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
03/01/2011
First use in commerce
03/30/2011
Drawing code
4
Owner type
16
Owner location
Langhorne, PA, US
Examiner
ROTH, BENJAMIN H.
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
The Lynx Group, LLC
The Lynx Group, LLC
Representatives
Brian L. Petrequin, Esq. Greenberg Traurig LLP
Technical classification
Nice Classes
Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed publicationsmagazinesjournalsnewslettersarticlesfeature reportsmonographssupplements to the foregoing in the fields hematologyoncologypharmacy
Publications
History of USPTO decisions and trademark events.
18 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/16/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/16/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/16/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/16/2026
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/15/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2022
ALIE
ASSIGNED TO LIE
02/03/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
02/02/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
01/28/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/28/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
01/28/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/28/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
01/28/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/28/2022
DOCK
ASSIGNED TO EXAMINER
01/19/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/11/2021
NWAP
NEW APPLICATION ENTERED
05/15/2021
Continuous trademark protection
Get notified about every new filing that threatens JOURNAL OF HEMATOLOGY ONCOLOGY PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.